NRI

Makers Laboratories Ltd

Sector Pharmaceuticals
BSE 506919
170.00
1.95 (1.16 %)
Buy
B
Sell
S
BSE

Overview

Day Low

169.00

Day High

170.85

52 Week Low

108.40

52 Week High

230.00

All Time Low

9.11

All Time High

330.83

Open

170.85

Close

168.05

Volume

6,415

Mkt cap (Cr)

100.30

P/E ratio

15.04

P/B ratio

0.66%

Div yield

0.00%

6M return

14.83%

1Y return

32.92%

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

170.00 1.16%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Makers Laboratories Ltd

Stock PE (TTM)

15.04

Promoter Holding

61.27%

Book Value

111.4207

ROCE

-2.19%

ROE

-7.27%

Makers Laboratores Limited (MLL) was incorporated in the State of Maharashtra, which commenced business from 21st July, 1984. The Company was promoted by Satish Kumar Gupta and Naval Tated. The Company is presently in manufacture of pharmaceutical formulations and drug intermediates. Makers Drugs & Food Products Ltd. (MDFP) was amalgamated with the Company with effect from 1st April 1993. As per terms of the scheme of amalgamation, the Company allotted 3,02,700 equity shares of the company fully paid, to the members of MDFPL in the ratio of 2 equity shares for every 1 equity share held by them in MDFPL. During 1996-97, MLL enhanced its installed capacity of Tablets/Capsules from 3000 to 3175 lacs and Oral/Liquids/Dry Syrups from 420000 to 500000 Ltrs and Ointments/Creams/External Liquids from 107000 to 120000 Kgs/Lit. MLL has gone for expansion in the year 1999. It has increased the installed capacity of Tablets & Capsules by 13.25 crores(Nos) and the company has again expanded the installed capacity of Tablets & Capsules in the year 2000 by 15.00 crores(Nos),taking the total capacity to 60.00 crores. The Modernisation of Formulation Drugs which was undertaken during 1999-2000 was completed successfully and this project was financed through Rights Issue of Equity Shares. The Palghar Plant Liquid Department was upgraded under the standard of schedule `M` during 2004. The Company sold its unviable formulations manufacturing unit at Palghar, in Thane Dist. during 2008. Harleystreet Pharmaceuticals Ltd. was merged with the Company by a Scheme of Amalgamation during the period 2011. In terms of the said Scheme of Amalgamation, 571,440 Equity shares of the Company of Rs 10/- each fully paid up were issued to the shareholders of HPL in the ratio of 6 fully paid up equity shares of Rs. 10/- each of the Company for every 10 fully paid up equity shares of Rs. 10/- each of HPL. i.e., 6:10. The Company sold its bulk drugs manufacturing unit at Dombivili, in Thane Dist. during the year 2016-17. It launched a new range of Diabetic & Hypertensive drugs including Voglibose, Gli-me range (Glimepiride Metformin Pioglitazone), Hypernorm range (Telmisartan). The Company further acquired 52,50,000 Equity shares of Rs 10/- each of Resonance Specialties Limited and became its subsidiary effective from 11th December, 2020. During 2020-21, the Company started manufacturing new ophthalmic eye drops at Naroda, in Ahmedabad in February, 2021. It started work on upgradation / modernization/capacity enhancement of its old liquid injectable manufacturing unit at Naroda, Gujarat in January, 2022.

Makers Laboratories share price as on 07 Feb 2025 is Rs. 170. Over the past 6 months, the Makers Laboratories share price has increased by 14.83% and in the last one year, it has increased by 32.92%. The 52-week low for Makers Laboratories share price was Rs. 108.4 and 52-week high was Rs. 230.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

506919

INE987A01010

Aug

Makers Laboratories Ltd FAQs

You can buy Makers Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Makers Laboratories Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Feb 07, 2025 04:01 PM the closing price of Makers Laboratories Ltd was Rs.170.00.

The latest PE ratio of Makers Laboratories Ltd as of Feb 07, 2025 04:01 PM is 15.04

The latest PB ratio of Makers Laboratories Ltd as of Feb 07, 2025 04:01 PM is 0.66

The 52-week high of Makers Laboratories Ltd share price is Rs. 230.00 while the 52-week low is Rs. 108.40

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Feb 07, 2025 04:01 PM, the market cap of Makers Laboratories Ltd stood at Rs. 100.30 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.